Smithfield Foods Inc. announced the launch of Smithfield Bioscience, a new strategic platform within the organization that leverages byproducts from the meat production process for the development of pharmaceuticals, nutraceuticals and medical device solutions.
“Smithfield is taking a leadership position in developing these types of cutting edge initiatives, which support a range of biotechnology solutions in areas of human therapeutics, tissue fabrication and regenerative medicine,” the company said in a statement.